查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1541732

2024-2032 年按测试类型（巴氏检测、HPV 检测、子宫颈活检、阴道镜检查等）、年龄层（20 至 35 岁、35 岁以上）和地区分類的子宫颈癌诊断市场报告

Cervical Cancer Diagnostics Market Report by Test Type (Pap Testing, HPV Testing, Cervical Biopsies, Colposcopy, and Others), Age Group (20 to 35 Years, Above 35 Years), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

2023年，全球IMARC Group宫颈癌诊断市场规模达80亿美元。

子宫颈癌诊断依赖一系列先进的实验室检查、工具和程序来评估异常细胞或人类乳突病毒 (HPV) 株。它们是透过采集透过锥切术、穿刺活检、子宫颈内膜刮除术和电线环获得的组织样本来进行的，以便在阴道镜检查期间对子宫颈进行彻底检查。检测后，进行血液、胸部X光、全身电脑断层扫描（CT）扫描、磁振造影（MRI）、正子断层扫描（PET）扫描以及膀胱和直肠目视检查等测试来确定疾病阶段。

被诊断患有梅毒、披衣菌、淋病和后天免疫缺乏症候群 (HIV/AIDS) 等性传染感染 (STI) 的人数大幅增加，导致全球 HPV 感染的风险不断上升。再加上吸烟者数量的增加，增加了罹患子宫颈癌的机会，这是推动市场成长的关键因素之一。此外，人们对早期诊断的认识不断提高，鼓励采用可提供快速、准确检测结果的 HPV 家庭检测试剂盒。有利的报销政策的存在也支持了市场的成长。除此之外，对个人化治疗计划的日益偏好正在增加对子宫颈癌诊断的需求。此外，一系列其他治疗方案的出现，包括手术、放射治疗、化疗、锥形活检、免疫治疗和子宫颈切除术，也促进了市场的成长。此外，对开发低成本和高效测试产品的日益重视预计将推动市场成长。

本报告回答的关键问题

  • 全球子宫颈癌诊断市场有多大？ 2024-2032年全球子宫颈癌诊断市场的预期成长率是多少？
  • 推动全球子宫颈癌诊断市场的关键因素是什么？
  • COVID-19 对全球子宫颈癌诊断市场有何影响？
  • 根据测试类型，全球子宫颈癌诊断市场的细分如何？
  • 全球子宫颈癌诊断市场的关键区域有哪些？
  • 全球子宫颈癌诊断市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球子宫颈癌诊断市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按测试类型

  • 巴氏测试
    • 市场趋势
    • 市场预测
  • HPV检测
    • 市场趋势
    • 市场预测
  • 子宫颈活检
    • 市场趋势
    • 市场预测
  • 阴道镜检查
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依年龄段

  • 20至35岁
    • 市场趋势
    • 市场预测
  • 35岁以上
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 9 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第13章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Arbor Vita Corporation
    • Becton, Dickinson and Company
    • Cooper Surgical Inc.
    • F. Hoffmann-La Roche AG
    • Guided Therapeutics Inc.
    • Hologic Inc.
    • Qiagen
    • Quest Diagnostics Incorporated
    • Siemens Healthcare GmbH
Product Code: SR112024A3175

The global cervical cancer diagnostics market size reached US$ 8.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.3 Billion by 2032, exhibiting a growth rate (CAGR) of 4.8% during 2024-2032.

Cervical cancer diagnostics rely on a series of advanced laboratory tests, tools and procedures to evaluate abnormal cells or strains of the human papillomavirus (HPV). They are performed by taking a sample of the tissue obtained through conization, punch biopsy, endocervical curettage and the electrical wire loop for a thorough examination of the cervix during colposcopy. After detection, tests like blood, chest X-ray, body computed tomography (CT) scan, magnetic resonance imaging (MRI), positron emission tomography (PET) scan and visual examination of bladder and rectum are conducted to determine the disease stage.

A considerable rise in the number of individuals diagnosed with sexually transmitted infections (STIs), such as syphilis, chlamydia, gonorrhea and acquired immune deficiency syndrome (HIV/AIDS), is escalating the risk of HPV infection worldwide. This, along with the growing number of smokers, which increases the chances of developing cervical cancer, represents one of the key factors bolstering the market growth. Furthermore, the rising awareness about early diagnosis is encouraging the adoption of HPV home testing kits that provide quick and accurate test results. The presence of favorable reimbursement policies also supports the market growth. Apart from this, rising preferences for personalized treatment plans are escalating the demand for cervical cancer diagnostics. Additionally, the availability of a range of other treatment options, including surgery, radiation therapy, chemotherapy, cone biopsy, immunotherapy and trachelectomy, is contributing to the market growth. Moreover, the growing emphasis on developing low-cost and efficient testing products is anticipated to fuel the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cervical cancer diagnostics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on test type and age group.

Breakup by Test Type:

Pap Testing

HPV Testing

Cervical Biopsies

Colposcopy

Others

Breakup by Age Group:

20 to 35 years

Above 35 years

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arbor Vita Corporation, Becton, Dickinson and Company, Cooper Surgical Inc., F. Hoffmann-La Roche AG, Guided Therapeutics Inc., Hologic Inc., Qiagen, Quest Diagnostics Incorporated and Siemens Healthcare GmbH.

Key Questions Answered in This Report

  • 1. How big is the global cervical cancer diagnostics market?
  • 2. What is the expected growth rate of the global cervical cancer diagnostics market during 2024-2032?
  • 3. What are the key factors driving the global cervical cancer diagnostics market?
  • 4. What has been the impact of COVID-19 on the global cervical cancer diagnostics market?
  • 5. What is the breakup of the global cervical cancer diagnostics market based on the test type?
  • 6. What are the key regions in the global cervical cancer diagnostics market?
  • 7. Who are the key players/companies in the global cervical cancer diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cervical Cancer Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Pap Testing
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 HPV Testing
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Cervical Biopsies
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Colposcopy
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Age Group

  • 7.1 20 to 35 years
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Above 35 years
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Arbor Vita Corporation
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Becton, Dickinson and Company
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Cooper Surgical Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 F. Hoffmann-La Roche AG
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Guided Therapeutics Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 SWOT Analysis
    • 13.3.7 Hologic Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Qiagen
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Quest Diagnostics Incorporated
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Siemens Healthcare GmbH
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 SWOT Analysis

List of Figures

  • Figure 1: Global: Cervical Cancer Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Cervical Cancer Diagnostics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Cervical Cancer Diagnostics Market: Breakup by Test Type (in %), 2023
  • Figure 5: Global: Cervical Cancer Diagnostics Market: Breakup by Age Group (in %), 2023
  • Figure 6: Global: Cervical Cancer Diagnostics Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Cervical Cancer Diagnostics (Pap Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Cervical Cancer Diagnostics (Pap Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Cervical Cancer Diagnostics (HPV Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Cervical Cancer Diagnostics (HPV Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Cervical Cancer Diagnostics (Cervical Biopsies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Cervical Cancer Diagnostics (Cervical Biopsies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Cervical Cancer Diagnostics (Colposcopy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Cervical Cancer Diagnostics (Colposcopy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Cervical Cancer Diagnostics (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Cervical Cancer Diagnostics (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Cervical Cancer Diagnostics (20 to 35 years) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Cervical Cancer Diagnostics (20 to 35 years) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Cervical Cancer Diagnostics (Above 35 years) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Cervical Cancer Diagnostics (Above 35 years) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: North America: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: North America: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: United States: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: United States: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Canada: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Canada: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Asia-Pacific: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Asia-Pacific: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: China: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: China: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Japan: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Japan: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: India: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: India: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: South Korea: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: South Korea: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Australia: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Australia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Indonesia: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Indonesia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Europe: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Europe: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Germany: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Germany: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: France: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: France: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: United Kingdom: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: United Kingdom: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Italy: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Italy: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Spain: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Spain: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Russia: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Russia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Latin America: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Latin America: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Brazil: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Brazil: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Mexico: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Mexico: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Middle East and Africa: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Middle East and Africa: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Middle East and Africa: Cervical Cancer Diagnostics Market: Breakup by Country (in %), 2023
  • Figure 70: Global: Cervical Cancer Diagnostics Industry: SWOT Analysis
  • Figure 71: Global: Cervical Cancer Diagnostics Industry: Value Chain Analysis
  • Figure 72: Global: Cervical Cancer Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cervical Cancer Diagnostics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
  • Table 3: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Age Group (in Million US$), 2024-2032
  • Table 4: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Cervical Cancer Diagnostics Market: Competitive Structure
  • Table 6: Global: Cervical Cancer Diagnostics Market: Key Players